As of January 22, 2025, Protara Therapeutics (TARA) has a market cap of $0.16 billion USD. According to our data, Protara Therapeutics is ranked No.7300 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.16 B |
-11.17%
|
Dec 31, 2024 | $0.18 B |
181.60%
|
Dec 29, 2023 | $65.17 M |
-30.04%
|
Dec 30, 2022 | $93.15 M |
-60.30%
|
Dec 31, 2021 | $0.23 B |
-72.12%
|
Dec 31, 2020 | $0.84 B |
47.62%
|
Dec 31, 2019 | $0.57 B |
-81.94%
|
Dec 31, 2018 | $3.16 B |
19.47%
|
Dec 29, 2017 | $2.64 B |
0.00%
|
Dec 30, 2016 | $2.64 B |
-87.75%
|
Dec 31, 2015 | $21.56 B |
49.13%
|
Dec 31, 2014 | $14.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
Verastem Oncology
VSTM
|
$0.25 B |
-0.000 M
|
USA
|
Aprea Therapeutics
APRE
|
$21.79 M |
0.000 M
|
USA
|
CytomX Therapeutics
CTMX
|
$65.57 M |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Market Cap | = | TARA Stock Price | * | TARA Shares Outstanding |
= | $4.69 | * | 34.76 M | |
= | $0.16 B |